Delivery Order SPE2DB24D2205-SPE2DB24FDYFF

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $68K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $54,107.14 and a period of performance through August 29, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide the specified medication to support federal healthcare programs and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $11,108.71 and a period of performance through May 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $6,311.56 and a period of performance through May 8, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets in 30-count packages, with a ceiling value of $29,035.47 and a period of performance ending on May 8, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Biktarvy 50-200-25 mg tablets, a specialty pharmaceutical product. It has a ceiling value of $20,118.85 and a completion date of October 26, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $43,363.83 and a performance period ending on April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $87,888.73 and a period of performance through September 9, 2024. The contract is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This contract is likely part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a prescription medication. The contract has a ceiling value of $13,933.44 and a completion date of June 6, 2025. This contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a prescription medication, at a firm fixed price of $5,991.17. The contract has an ultimate completion date of May 2, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp, the prime contractor, holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Biktarvy 50-200-25 mg tablets, a specialty medication. The contract has a ceiling value of $36,443.00 and a period of performance through January 5, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition....
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDYFF
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $67,963.45 and a completion date of August 12, 2024. It is a firm-fixed-price contract, which indicates the price is predetermined and not subject to adjustment. The contract does not have a set-aside designation. AmerisourceBergen, through its extensive supply chain network, will provide these critical pharmaceutical products to support various military treatment facilities and federal healthcare programs nationwide. This contract is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025 for the delivery of a comprehensive range of medical commodities.

Generated 11/8/24, 9:02 AM